Ann Tsukamoto - StemCells Insider

StemCells Inc -- USA Stock  

 1.28  0.02  1.59%

Executive VP of Scientific and Strategic Alliances

Dr. Ann Tsukamoto Ph.D. is Executive Vice President Scientific and Strategic Alliances of StemCells Inc. She was appointed Vice President Scientific Operations in June 1998 Vice President Research and Development in February 2002 Chief Operating Officer in November 2006 and Executive Vice President Research and Development in October 2008. In June 2013 Dr. Tsukamoto was appointed Executive Vice President Scientific and Strategic Alliances with responsibility for developing the Companys alliances with research institutions corporations government agencies and disease foundations. Dr. Tsukamoto is married to one of our outside directors.
Age: 61  EVP Since 2013      
510-456-4000  http://www.stemcellsinc.com

Management Efficiency

The company has return on total asset (ROA) of (92.96) % which means that it has lost $92.96 on every $100 spent on asset. This is way below average.
The company currently holds 2 M in liabilities with Debt to Equity (D/E) ratio of 1.6 which is about average as compared to similar companies. StemCells Inc has Current Ratio of 0.6 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.

Similar Executives

Entity Summary

StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cellbased therapeutics and related technologies. StemCells Inc (STEM) is traded on Nasdaq Capital Markets in USA. It is located in Newark, CA and employs 74 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add StemCells Inc to your portfolio

Top Management

StemCells Inc Leadership Team
Alan Trounson, Director
Irving Weissman, Director
John Schwartz, Chairman, Ph.D
Gregory Schiffman, President
Martin McGlynn, CEO
Ian Massey, President, Ph.D
Scott Greer, Director
Kenneth Stratton, Executive
Ricardo Levy, Director
Ann Tsukamoto, EVP
Eric Bjerkholt, Director
R Greer, Director

Stock Performance

StemCells Performance Indicators